280 related articles for article (PubMed ID: 25792011)
1. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
[No Abstract] [Full Text] [Related]
2. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
4. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
[No Abstract] [Full Text] [Related]
6. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
Wang L; Gao T; Wang G
J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
[TBL] [Abstract][Full Text] [Related]
7. Six-year-old girl with primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Kikuchi Y; Kashii Y; Gunji Y; Morimoto A; Masuzawa A; Takatsuka Y; Fujita E; Komine M; Ohtsuki M; Matsubara D; Kobayashi C; Sakurai A; Yanase K; Kato K; Koike K; Tsuchida M; Momoi MY
Pediatr Int; 2011 Jun; 53(3):393-6. PubMed ID: 21696508
[No Abstract] [Full Text] [Related]
8. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
Marzano AV; Vezzoli P; Fanoni D; Venegoni L; Berti E
J Am Acad Dermatol; 2009 Aug; 61(2):348-55. PubMed ID: 19615546
[TBL] [Abstract][Full Text] [Related]
9. Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
Johnson WT; Leeman-Neill RJ; Patel P; Ho J; Grandinetti LM; Jedrych J; Craig FE
Am J Dermatopathol; 2016 Nov; 38(11):832-837. PubMed ID: 27322928
[TBL] [Abstract][Full Text] [Related]
10. [Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
Du-Thanh A; Durand L; Costes V; Guillot B; Dereure O
Ann Dermatol Venereol; 2006 Dec; 133(12):991-4. PubMed ID: 17185931
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.
Fujimoto N; Kito K; Yoshida T; Tanaka T
Acta Derm Venereol; 2015 Jan; 95(1):106-7. PubMed ID: 24890876
[No Abstract] [Full Text] [Related]
12. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
Kim SK; Kim YC; Kang HY
J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion.
Kasuya A; Hirakawa S; Tokura Y
Dermatol Online J; 2012 Oct; 18(10):5. PubMed ID: 23122012
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous aggressive epidermotropic CD4/CD8 double-negative cytotoxic T-cell lymphoma.
Akkari H; Belhadjali H; Moussa A; Youssef M; Zili J
Pathologica; 2012 Apr; 104(2):78-81. PubMed ID: 22953504
[TBL] [Abstract][Full Text] [Related]
15. Primary Cutaneous Gamma-Delta T-cell Lymphoma: Not an Aggressive Disease in All Cases.
Khallaayoune M; Grange F; Condamina M; Szablewski V; Guillot B; Dereure O
Acta Derm Venereol; 2020 Jan; 100(1):adv00035. PubMed ID: 31612963
[No Abstract] [Full Text] [Related]
16. Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype.
Shimauchi T; Sugita K; Nakamura M; Tokura Y
Acta Derm Venereol; 2010; 90(1):68-72. PubMed ID: 20107729
[TBL] [Abstract][Full Text] [Related]
17. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab.
Jacks SM; Taylor BR; Rogers RP; Ralston JS; Metcalf JS; Lazarchick J
J Am Acad Dermatol; 2014 Sep; 71(3):e86-7. PubMed ID: 25128139
[No Abstract] [Full Text] [Related]
18. Epidermotropic CD8+ cytotoxic T-cell lymphoma exhibiting a transition from the indolent to the aggressive phase, accompanied by emergence of CD7+ cells and formation of neutrophilic pustules.
Ito Y; Goto M; Hatano Y; Kawamoto M; Ohishi M; Takayasu S; Katagiri K; Fujiwara S
Clin Exp Dermatol; 2012 Mar; 37(2):128-31. PubMed ID: 21883402
[TBL] [Abstract][Full Text] [Related]
19. CD4-CD8-"Double-negative" cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course.
Jones D; Vega F; Sarris AH; Medeiros LJ
Am J Surg Pathol; 2002 Feb; 26(2):225-31. PubMed ID: 11812944
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier.
Ohmatsu H; Sugaya M; Fujita H; Miyagaki T; Kadono T; Maeda D; Takazawa Y; Fukayama M; Tamaki K; Sato S
Acta Derm Venereol; 2010 May; 90(3):324-5. PubMed ID: 20526566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
